Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia
Jérémie Zerbit, Jérôme Tamburini, Lauriane Goldwirt, Justine Decroocq, Jean Michel Cayuela, Nicolas Chapuis, Adrien Contejean, Rui Batista, Didier Bouscary, Lise Willems
Abstract
Since the development of tyrosine kinase inhibitors (TKIs) targeting BCR/ABL1 and significantly improved outcomes on long-term disease-free survival in Philadelphia chromosome–positive (Ph+) acute ...
Topics & Concepts
PonatinibLymphoblastic LeukemiaMedicinePhiladelphia chromosomeCancer researchInternal medicineOncologyLeukemiaMyeloid leukemiaGeneticsBiologyDasatinibChromosomal translocationGeneImatinibChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchChronic Lymphocytic Leukemia Research